# Opus Genetics, Inc.: Form 8-K, filed Oct 21, 2026

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 8-K
- Filed: 2026-10-21
- Accepted by EDGAR: Oct 21, 2026, 16:05 ET
- Period: 2026-10-19
- Accession: 0001140361-26-040377
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036126040377/ef20084050_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036126040377/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036126040377/ef20084050_8k.htm

Filed Oct 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-040377. Last ingested by Listed: Nov 5, 2026, 16:37 ET. No prices; not investment advice.